The overall uptake of RSV vaccine is low during its first season in those aged 60 years or older in the United States. The ...

A study by former Junior Associate Professor Kazuo Takayama, currently a professor of the Institute of Science Tokyo, ...

A Spanish study found that nirsevimab prophylaxis significantly reduced infant hospitalizations, ICU admissions, and severe ...

The health and human services secretary, Robert F. Kennedy Jr., is known for his criticism of advisory panels, most recently ...

After the monoclonal antibody nirsevimab (Beyfortus) became available to prevent respiratory syncytial virus (RSV) in infants ...

The seasonal timing of when infants receive the new respiratory syncytial virus (RSV ... specific target—nirsevimab binds to ...

A seasonal flu virus that can lead to paralysis has been detected in California wastewater. Influenza B has been shown at a ...

Vaccines using mRNA are currently being studied for a wide range of diseases, including cancer, cardiovascular disease, ...